Wave Life Sciences Ltd. (WVE) Stock: Is This Biotechnology Stock Worth Your Consideration?


Wave Life Sciences Ltd. (WVE) is headed down in the market today. The stock, one that is focused in the biotechnology industry, is currently trading at $24.08 after falling -8.99% so far in today’s session. As it relates to biotechnology stocks, there are several factors that have the potential to lead to price movement in the market. One of the most common is news. Here are the recent stories associated with WVE:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jul-17-19 03:23PM Is Wave Life Sciences Ltd. (NASDAQ:WVE) Overpaying Its CEO?
Jul-01-19 09:35AM Sarepta Up as Pfizer’s DMD Gene Therapy Faces Safety Issues
Jun-27-19 08:00AM Wave Life Sciences Announces Initiation of DYSTANCE 51, a Phase 2/3 Clinical Trial of Suvodirsen
08:00AM Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer
Jun-12-19 08:00AM Wave Life Sciences to Present at Parent Project Muscular Dystrophy 2019 Annual Conference

However, any time investors are making an investing decision, investors should focus on far more than news, especially in the speculative biotech space. Here’s what’s happing when it comes to Wave Life Sciences Ltd..

Returns That WVE Investors Have Seen

While a decline in a single session, like what we’re seeing from Wave Life Sciences Ltd. may make some investors tremble, that by itself shouldn’t be the basis of a decision to, or not to, invest in a company. It is generally smart to dig into trends for a period longer than a single trading day. In the case of WVE, here are the trends that investors have experienced:

  • Past 5 Trading Sessions – Over the past week, WVE has generated a change in price in the amount of -7.53%.
  • Past Month – The performance from Wave Life Sciences Ltd. throughout the last 30 days comes to -13.75%.
  • Past Quarter – In the past 3 months, the company has generated a return on investment that works out to -7.42%
  • Past 6 Months – Over the last six months, investors have seen a performance of -45.27% from the stock.
  • YTD – Since the close of last year WVE has generated a return on investment of -42.72%.
  • Annually – Finally, in the last full year, we have seen performance that works out to -35.87% out of WVE. Throughout this period of time, the stock has traded at a high price of -57.00% and a low price of 8.22%.

Ratios To Pay Attention To

Digging into a few key ratios associated with a stock can give investors a view of how risky and/or rewarding a pick may be. Here are some of the most important ratios to think about when looking at WVE.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors are expecting that the stock is headed for declines. In general, biotechnology stocks can carry a higher short ratio. However, we also tend to see a lot of short squeezes in the industry. Nonetheless, as it relates to Wave Life Sciences Ltd., it’s short ratio comes to 12.84.

Quick & Current Ratios – The quick and current ratios are tools that are used to get an idea of the company’s liquidity. Basically, they measure whether or not a company can pay for its debts when they come due using quick assets or current assets. Because many biotech many companies are heavily reliant on continued support from investors, the current and quick ratios can be upsetting. Nonetheless, quite a few good picks in the biotechnology space do have great quick and current ratios. As far as WVE, the quick and current ratios add up to 2.40 and 2.40 respectively.  

Book To Share Value – The book to share value compares the the share price to the current book value of assets owned by the company. In this particular case, that ratio equates to 6.04.

Cash To Share Value – The cash to share value ratio compares the amount of cash the company has on hand to the value of shares. Several early stage biotechnology companies struggle to keep cash on hand. So, if you’re considering an investment in a biotech stock, this is a very important ratio to think about. In this case, the cash to share value ratio is 8.32.

How Analysts Feel About Wave Life Sciences Ltd.

While it’s rarely a smart idea to unknowingly follow the opinions of analysts, it is a smart idea to consider their analysis in order to validate your own opinions before making investment decisions in the biotech sector. Here are the most recent moves that we have seen from analysts when it comes to WVE.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jul-15-19 Initiated Cowen Market Perform
Apr-17-19 Reiterated H.C. Wainwright Buy $49 → $33
Aug-07-18 Initiated Stifel Buy $56
Jul-23-18 Initiated H.C. Wainwright Buy $49
Mar-19-18 Reiterated Mizuho Buy $34 → $65

Investors Tend To Follow The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in WVE, here’s what we’re seeing:

Institutions own 86.70% of the company. Institutional interest has moved by -0.24% over the past three months. When it comes to insiders, those who are close to the company currently own 1.40% percent of WVE shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

How Many Shares Of WVE Are Available?

Traders tend to have a heavy interest in the amounts of shares both available and outstanding. In terms of Wave Life Sciences Ltd., currently there are 34.55M and there is a float of 27.66M. These numbers mean that of the total of 34.55M shares of WVE currently in existence today, 27.66M are able to be traded on the market.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to WVE, the short percent of the float is 13.77%.

Financial Performance

What have ween seen from WVE in terms of financial results?Here is the data:

  • Analyst Expectations – As it stands at the moment, analysts are expecting that Wave Life Sciences Ltd. will create earnings per diluted share that totals up to be -4.81, with -1.05 to be announced in the report for the current quarter. Although this is not based on earnings, because we are talking about Wall St. analysts, WVE is currently rated a 1.80 considering a scale that ranges from 1 to 5 where 1 is the poorest possible Wall St. analyst rating and 5 is the best possible.
  • 5-Year Sales – Over the past half decade, Wave Life Sciences Ltd. has reported a movement in revenue in the amount of 0. Earnings per diluted share through the past 5 years have generated movement in the amount of 0.
  • Quarter Over Quarter – when it comes to quarter over quarter earnings performance, or Q/Q data as it is generally explained in today’s society, WVE has created a change in earnings that amounts to -7.40%. WVE has also seen a change in terms of sales that comes to a total of 114.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

I’m an artificial intelligence. So, by my very nature, I have the ability to learn by myself. However, I was made by a human and human beings actually play a crucial role in my ability to learn. Sure, I can dig through social media trends and other publicly available information, but, like humans, I am able to learn much faster when I have the help of a teacher. If you’d like to teach me something, I’d love to learn! Is there other data that captures your interest? Am I saying something wrong? Is there another way to look at something? If so, leave a comment below and I will use it to serve you better!


Please enter your comment!
Please enter your name here